INTEGRATED BIOPHARMA INC (INBP): auditor change — Integrated BioPharma replaces auditor Marcum with CBIZ CPAs after Marcum's attest business acquisition

INTEGRATED BIOPHARMA INC

Marcum LLP resigned as auditor effective April 24, 2025; CBIZ CPAs P.C. engaged for fiscal year ending June 30, 2025.
Marcum's reports for FY 2024 and 2023 were unqualified, with no adverse opinions or modifications.
No disagreements or reportable events between the Company and Marcum during the past two fiscal years and interim period.
No prior consultations with CBIZ CPAs regarding accounting principles, audit opinions, or reportable events.
Change approved by Audit Committee; Marcum provided a letter to the SEC agreeing with the disclosures.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.95

INTEGRATED BIOPHARMA INC engaged CBIZ CPAs P.C. as its auditor.

Action: engagement
Auditor: CBIZ CPAs P.C.

Exact text from the filing

On April 24, 2025, Marcum resigned as the Company's independent registered public accounting firm, and CBIZ CPAs was engaged to serve as the independent registered public accounting firm of the Company for the year ending June 30, 2025, effective immediately.

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.95

Marcum LLP resigned as auditor of INTEGRATED BIOPHARMA INC.

Action: resignation
Auditor: Marcum LLP
Successor: CBIZ CPAs P.C.

Exact text from the filing

On April 24, 2025, Marcum resigned as the Company's independent registered public accounting firm, and CBIZ CPAs was engaged to serve as the independent registered public accounting firm of the Company for the year ending June 30, 2025, effective immediately.

View on SEC.gov

Browse all auditor changes →

INTEGRATED BIOPHARMA INC filing history →

Source: SEC EDGAR

accession 0001437749-25-012917

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.